SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jacob Staffan)
 

Sökning: WFRF:(Jacob Staffan) > Intracellular Deliv...

Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6

Dash-Wagh, Suvarna (författare)
Karolinska Institutet,Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
Jacob, Stefan (författare)
Karolinska Institutet,Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden
Lindberg, Staffan (författare)
Stockholms universitet,Institutionen för neurokemi,Department of Neurochemistry, Stockholm University, Stockholm, Sweden
visa fler...
Fridberger, Anders, 1966- (författare)
Karolinska Institutet,Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden
Langel, Ülo (författare)
Stockholms universitet,Institutionen för neurokemi,Department of Neurochemistry, Stockholm University, Stockholm, Sweden
Ulfendahl, Mats (författare)
Karolinska Institutet,Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
visa färre...
 (creator_code:org_t)
Elsevier BV, 2012
2012
Engelska.
Ingår i: Molecular Therapy Nucleic Acids. - : Elsevier BV. - 2162-2531. ; 1:e61
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • RNA interference (RNAi) using short interfering RNA (siRNA) is an attractive therapeutic approach for treatment of dominant-negative mutations. Some rare missense dominant-negative mutations lead to congenital-hearing impairments. A variety of viral vectors have been tested with variable efficacy for modulating gene expression in inner ear. However, there is concern regarding their safety for clinical use. Here, we report a novel cell-penetrating peptide (CPP)-based nonviral approach for delivering siRNA into inner ear tissue using organotypic cultures as model system. PepFect6 (PF6), a variant of stearyl-TP10, was specially designed for improved delivery of siRNA by facilitating endosomal release. We show that PF6 was internalized by all cells without inducing cytotoxicity in cochlear cultures. PF6/siRNA nanoparticles lead to knockdown of target genes, a housekeeping gene and supporting cell-specific connexin 26. Interestingly, application of PF6/connexin 26 siRNA exhibited knockdown of both connexin 26 and 30 mRNA and their absence led to impaired intercellular communication as demonstrated by reduced transfer of calcein among the PF6/connexin 26-siRNA-treated cells. Thus, we conclude that PF6 is an efficient nonviral vector for delivery of siRNA, which can be applied as a tool for the development of siRNA-based therapeutic applications for hearing impairments.

Ämnesord

NATURVETENSKAP  -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

cell-penetrating peptide (CPP)
cochlea
connexin
FRAP
gap junctions
gene therapy
inner ear
nanoparticles
siRNA
neurokemi med molekylär neurobiologi
Neurochemistry with Molecular Neurobiology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy